Endocrine Disorders, Fertility, and Sexual Health-Reference-Cited by-同舟云学术

Endocrine Disorders, Fertility, and Sexual Health

Published:2024 Issue: Volume: Page:501-509
ISSN:
Container-title:The EBMT Handbook
language:en
Short-container-title:

Author:

Salooja Nina,Rovó Alicia,Dalle Jean-Hugues

Abstract

AbstractIncreasing numbers of HCT are being performed annually and outcomes continue to improve. As a result, survivorship issues are assuming increasing importance. Chemotherapy and radiotherapy remain cornerstones of HCT treatment, but, while lifesaving, they threaten endocrine function, fertility, and sexual function.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-44080-9_56

Reference54 articles.

1. ASRM Practice Committee. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112:1022–33.

2. Ataca Atilla P, Akkus E, Atilla E, et al. Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation. Clin Transplant. 2020;34:e14049.

3. Balduzzi A, Dalle JH, Jahnukainen K, et al. Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group. Bone Marrow Transplant. 2017;52:1406–15.

4. Bevans M, El-Jawahri A, Tierney DK, et al. National Institutes of Health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transplant. 2017;23:538–51.

5. Bhatia S, Armenian SH, Landier W. How I monitor long-term and late effects after blood or marrow transplantation. Blood. 2017;130:1302–14.